China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
ROCHESTER, N.Y., Feb. 28, 2017 -- Transcat, Inc. (NASDAQ:TRNS), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that Lee D. Rudow, President and Chief Executive Officer, and Michael J. Tschiderer, Chief Financial Officer, will present and be available for investor meetings at two conferences in March.
ROTH Capital Partners’ 29th Annual Conference in Dana Point, CA on Tuesday, March 14, 2017
The Transcat presentation is scheduled to begin at 5:30 p.m. PT (8:30 p.m. ET). A link to the live webcast of the presentation, along with presentation materials, will be available at www.transcat.com/investor-relations. Management will also be available for investor meetings between 7:00 a.m. and 6:00 p.m. PT. An archive of the Company’s presentation will be available in the Investor Relations section of the website, along with a transcript once available.
Sidoti & Company Spring 2017 Convention in New York City on Wednesday, March 29, 2017
For those in attendance, the Transcat presentation is scheduled to begin at 3:00 p.m. ET. Management will also be available for investor meetings between 8:00 a.m. and 4:45 p.m. ET. There will be no webcast for this presentation.
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, including life science, aerospace and defense, pharmaceutical, medical device manufacturing and biotechnology. Transcat provides permanent and periodic on-site services, mobile calibration services and in-house services through 20 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.
Transcat also operates as a leading value-added distributor that markets, sells and rents national and proprietary brand instruments to customers globally. Its e-commerce focused website and product catalog offer access to more than 100,000 test, measurement and control instruments, including products from approximately 540 leading manufacturers.
Transcat’s growth strategy is to leverage its service capabilities, strong brand and leading distribution platform to drive organic sales growth and to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.
More information about Transcat can be found at: Transcat.com.
For more information, contact: Michael J. Tschiderer Chief Financial Officer Phone: (585) 352-7777 Email: [email protected] Deborah K. Pawlowski Investor Relations Phone: (716) 843-3908 Email: [email protected]
